Login / Signup
Kenta Anjo
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Squamous Cell
Tyrosine Kinase
Double Blind
Phase Iii
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Hitomi Sumiyoshi Okuma
,
Keisuke Watanabe
,
Kenji Tsuchihashi
,
Ryunosuke Machida
,
Ryo Sadachi
,
Akihiro Hirakawa
,
Hiroshi Ariyama
,
Masashi Kanai
,
Masahisa Kamikura
,
Kenta Anjo
,
Akari Hiramitsu
,
Shigeki Sekine
,
Natsuko Okita
,
Hiroyuki Mano
,
Hiroyoshi Nishikawa
,
Kenichi Nakamura
,
Kan Yonemori
Phase 2 trial of nivolumab in metastatic rare cancer with dMMR or MSI-H and relation with immune phenotypic analysis (the ROCK trial).
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)